Devonian Health Group Stock Current Valuation
| GSD Stock | CAD 0.16 0.01 5.88% |
Valuation analysis of Devonian Health Group helps investors to measure Devonian Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Devonian Health's Cash is fairly stable compared to the past year. Change In Cash is likely to climb to about 5.8 M in 2025, despite the fact that Other Cashflows From Financing Activities is likely to grow to (240.1 K). Fundamental drivers impacting Devonian Health's valuation include:
Price Book 1.636 | Enterprise Value 13.5 M | Enterprise Value Ebitda 96.4872 | Price Sales 2.432 | Enterprise Value Revenue 0.6043 |
Overvalued
Today
Please note that Devonian Health's price fluctuation is out of control at this time. Calculation of the real value of Devonian Health Group is based on 3 months time horizon. Increasing Devonian Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Devonian stock is determined by what a typical buyer is willing to pay for full or partial control of Devonian Health Group. Since Devonian Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Devonian Stock. However, Devonian Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.16 | Real 0.14 | Hype 0.15 |
The intrinsic value of Devonian Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Devonian Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Devonian Health Group helps investors to forecast how Devonian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Devonian Health more accurately as focusing exclusively on Devonian Health's fundamentals will not take into account other important factors: Devonian Health Group Company Current Valuation Analysis
Devonian Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Devonian Health Current Valuation | 13.53 M |
Most of Devonian Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Devonian Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Devonian Health Group has a Current Valuation of 13.53 M. This is 99.91% lower than that of the Biotechnology sector and 99.71% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.92% higher than that of the company.
Devonian Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devonian Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Devonian Health could also be used in its relative valuation, which is a method of valuing Devonian Health by comparing valuation metrics of similar companies.Devonian Health is currently under evaluation in current valuation category among its peers.
Devonian Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0812 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 13.53 M | ||||
| Shares Outstanding | 148.22 M | ||||
| Shares Owned By Insiders | 14.20 % | ||||
| Number Of Shares Shorted | 6.79 K | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 2.43 X | ||||
| Revenue | 17.82 M | ||||
| Gross Profit | 3.02 M | ||||
| EBITDA | (2.46 M) | ||||
| Net Income | (1.22 M) | ||||
| Cash And Equivalents | 413.87 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 2.08 M | ||||
| Debt To Equity | 43.00 % | ||||
| Current Ratio | 0.95 X | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | 5.63 M | ||||
| Short Ratio | 1.66 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 23.72 M | ||||
| Total Asset | 30.73 M | ||||
| Retained Earnings | (26.65 M) | ||||
| Working Capital | 2.31 M | ||||
| Net Asset | 30.73 M |
About Devonian Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Devonian Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devonian Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devonian Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.